SUMMARY

Persons with hemophilia in the United States, Latin America, Europe, Asia, the Middle East and Africa were infected with contaminated blood products. Lieff Cabraser is representing clients from around the world in lawsuits filed in U.S. courts against American blood companies that sold in the U.S. and exported contaminated blood worldwide.


PRESS RELEASE

Lieff Cabraser Heimann & Bernstein, LLP, Announces Filing Of Lawsuit In The United States On Behalf Of Hemophiliacs Worldwide Including Argentines

American Companies Alleged To Have Exported To Argentina Blood Product Discontinued For Sale In The U.S. Due To Safety Concerns
Deutsche [html]
Italiano [html]
Español [html]
Portugese [html]
Mandarin [Adobe Acrobat format]
Japanese [Adobe Acrobat format]
Korean [Adobe Acrobat format]
June 4, 2003, San Francisco, CA -- Lieff Cabraser Heimann & Bernstein, LLP, announced that it has filed a lawsuit, entitled Domenico Gullone, et al. v. Bayer Corporation, et al., on behalf of hemophiliacs, or their survivors and estates, living outside the United States, including hemophiliacs from Argentina, who became infected with HIV and/or Hepatitis C ("HCV") from contaminated blood products manufactured by American companies. The blood products were known as factor concentrate, Factor VIII ("antihemophilic factor" or "AHF") and Factor IX, and were manufactured and sold in the U.S., and exported worldwide. The lawsuit was filed in federal district court in San Francisco.
The lawsuit alleges that the American companies sought to maximize profits at the expense of the health and lives of thousands of hemophiliacs worldwide who were needlessly infected with HIV and/or HCV. AIDS is the leading cause of death for hemophiliacs who were treated with non heat-treated factor concentrate in the 1980's, and the average life expectancy of hemophiliacs has decreased substantially. In Latin America, at least 700 HIV cases are linked to use of contaminated blood products by hemophiliacs. Thousands more around the world allegedly were infected with Hepatitis C from blood products produced by American companies.
The lawsuit alleges that these companies intentionally sold blood factor that they knew or should have known to be infected with the agents that cause AIDS and HCV. "This is a worldwide tragedy that had a particular impact in Argentina," stated Lieff Cabraser partner Robert Nelson. According to recent press reports, one American company, Cutter Biological, in 1985 sold 300,000 units of blood factor concentrate to Argentina that it knew or should have known was most likely infected with the agents that cause AIDS and HCV. Cutter Biological had changed the way it manufactured the product to reduce the risk of HIV and hepatitis transmission, but had a significant stock of blood factor made from the old method. "Instead of destroying the defective stock, Cutter allegedly shipped it to Argentina for use by hemophiliacs there," said Nelson.
The lawsuit seeks to require that the American companies that made these contaminated products acknowledge their responsibility to hemophiliacs in Argentina and worldwide and to their families. The American companies, or their subsidiaries, named as defendants in the lawsuit were engaged in the manufacture, production and sale of Factor VIII and IX and/or their plasma components. The defendants include: Bayer Corporation and its Cutter Biological division, Baxter Healthcare Corporation and its Hyland Pharmaceutical division, Armour Pharmaceutical Company and Alpha Therapeutic Corporation.
About Lieff Cabraser
Lieff Cabraser Heimann & Bernstein, LLP is a fifty-plus attorney law firm with offices in San Francisco, New York and Nashville. Since 1972, Lieff Cabraser has successfully represented residents of the United States and persons living abroad in a wide range of cases, including personal injury lawsuits. The firm has successfully litigated against the nation's cigarette manufacturers, and against some of the country's largest pharmaceutical, insurance, securities and software companies. Since 1992, Lieff Cabraser has litigated thirty-five separate cases in which $100 million or more jury verdicts were rendered or settlements were reached, including ten cases each valued at $1 billion or more. Assisting Lieff Cabraser with the litigation is the Law Offices of Charles Kozak.

Source/Contact:
Heather Foster
LIEFF CABRASER HEIMANN & BERNSTEIN, LLP
275 Battery Street, 30th Floor
San Francisco, CA 94111
Tel: (415) 956-1000
Fax: (415) 956-1008